{
  "ptid_time": "031_S_4476_2012-04-20",
  "img_path": "/data/qiuhui/data/adni/images/031_S_4476/2012-04-20/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 36,288 mm³, 22.8% below the reference mean. With a Z-score of -0.66 (25.4th percentile), this represents normal volume ; hippocampal volume measures 5,787 mm³, 17.0% below the reference mean. With a Z-score of -1.46 (7.2th percentile), this represents mild atrophy; whole brain volume measures 937,581 mm³, 8.9% below the reference mean. With a Z-score of -1.17 (12.2th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,592 mm³, 9.5% below the reference mean. With a Z-score of -0.62 (26.7th percentile), this represents normal volume ; fusiform gyrus volume measures 13,960 mm³, 22.7% below the reference mean. With a Z-score of -1.97 (2.5th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 17,642 mm³, 12.5% below the reference mean. With a Z-score of -1.12 (13.0th percentile), this represents mild atrophy. ",
  "text_data": "Age is 88.6 years. Gender is Male. Education: 11 years. Handedness: Right. Race: Asian. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Smoking; Malignancy; Major Surgical Procedures. MMSE: 30.0. MoCA: 22.0. Logical Memory: 8.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.01 SUVR (normal ); Total tau: 258.90 pg/mL (normal ); Phosphorylated tau: 23.75 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild to moderate atrophy in key regions associated with Alzheimer's disease (hippocampus, fusiform gyrus, middle temporal gyrus), while ventricular and entorhinal cortex volumes are normal. Despite normal CSF biomarkers and amyloid PET (AV45), the MoCA score of 22 suggests cognitive impairment, while the MMSE of 30 is incongruent (possibly due to ceiling effects or test limitations). Given the age and APOE4-negative status, neurodegeneration may be driven by non-AD pathology (e.g., age-related, vascular, or other tauopathies).  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to conflicting MMSE/MoCA scores and normal biomarkers despite structural atrophy)",
  "timestamp": "2025-07-26T04:49:19.344784"
}